 Stage 1, London: HIV-1 infected males or females of at least 18 years, treated with a stable efavirenz based combination regimen tenofovir emtricitabine or tenofovirlamivudine or zidovudinelamivudine for at least the preceding 12 weeks and with an undetectable viral load and a CD4 T-cell count 100 cellmm3. 